Groupe Hospitalier de la Rochelle Ré Aunis — La Rochelle

Public research footprint of Groupe Hospitalier de la Rochelle Ré Aunis, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Giant Cell Arteritis (GCA) · Atrial Fibrillation · Heart Failure with Mid-range Ejection Fraction · Heart Failure with Preserved Ejection Fraction

Recently updated registry entries

NCT07732270 — Evaluation of a Paraclinical Test for the Diagnosis of Arterial Insufficiency in Diabetic… (Not Yet Recruiting)
NCT07729683 — Evaluation of the Effect of a Daily Dose of Wakame Seaweed on Reducing Circulating… (Recruiting)
NCT07048795 — Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Groupe Hospitalier de la Rochelle Ré Aunis?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.